康辰药业
(603590)
| 流通市值：38.89亿 | | | 总市值：39.45亿 |
| 流通股本：1.59亿 | | | 总股本：1.61亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 640,216,699 | 462,795,750.69 | 214,870,397.3 | 915,123,690.39 |
| 营业总成本 | 531,907,499.73 | 354,733,995.85 | 156,475,838.57 | 724,859,248.04 |
| 其他经营收益 | | | | |
| 营业利润 | 131,306,877 | 126,038,331.53 | 60,552,430.3 | 203,016,640.4 |
| 利润总额 | 124,007,056.92 | 120,938,801.56 | 58,702,330.35 | 189,686,430.81 |
| 净利润 | 104,192,295.32 | 100,564,729.4 | 48,512,063.09 | 169,423,424.87 |
| 每股收益 | | | | |
| 其他综合收益 | -23,057,015.72 | -23,579,061.36 | 4,785,418.36 | -10,653,418.31 |
| 综合收益总额 | 81,135,279.6 | 76,985,668.04 | 53,297,481.45 | 158,770,006.56 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,346,878,361.33 | 1,389,783,262.73 | 1,322,653,489.81 | 1,395,528,838.13 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,767,911,818.05 | 2,730,786,937.12 | 2,754,522,521.09 | 2,699,466,329.56 |
| 资产总计 | 4,114,790,179.38 | 4,120,570,199.85 | 4,077,176,010.9 | 4,094,995,167.69 |
| 流动负债: | | | | |
| 流动负债合计 | 522,347,789.01 | 544,897,320.26 | 433,812,505.06 | 459,447,457.05 |
| 非流动负债: | | | | |
| 非流动负债合计 | 109,938,221.71 | 101,025,064.53 | 135,597,066.34 | 139,063,293.77 |
| 负债合计 | 632,286,010.72 | 645,922,384.79 | 569,409,571.4 | 598,510,750.82 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,192,903,833.91 | 3,184,597,536.71 | 3,221,259,791.28 | 3,211,276,257.44 |
| 股东权益合计 | 3,482,504,168.66 | 3,474,647,815.06 | 3,507,766,439.5 | 3,496,484,416.87 |
| 负债和股东权益合计 | 4,114,790,179.38 | 4,120,570,199.85 | 4,077,176,010.9 | 4,094,995,167.69 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 712,609,102.57 | 485,408,142.4 | 244,911,400.88 | 992,029,766.77 |
| 经营活动现金流出小计 | 671,939,866.65 | 480,849,472.39 | 224,314,436.42 | 876,351,418.68 |
| 经营活动产生的现金流量净额 | 40,669,235.92 | 4,558,670.01 | 20,596,964.46 | 115,678,348.09 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 755,794,443.88 | 624,110,260.87 | 517,833,367.2 | 1,213,447,484.34 |
| 投资活动现金流出小计 | 697,467,270.89 | 638,125,548.03 | 478,961,190.4 | 1,169,155,297.35 |
| 投资活动产生的现金流量净额 | 58,327,172.99 | -14,015,287.16 | 38,872,176.8 | 44,292,186.99 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 330,157,719 | 122,694,915 | 43,974,915 | 298,867,756.47 |
| 筹资活动现金流出小计 | 356,778,674.29 | 129,428,389.9 | 78,570,025.44 | 316,216,372.88 |
| 筹资活动产生的现金流量净额 | -26,620,955.29 | -6,733,474.9 | -34,595,110.44 | -17,348,616.41 |
| 汇率变动对现金及现金等价物的影响 | -172,280.33 | -136,993.57 | -84,904.01 | -26,524.81 |
| 现金及现金等价物净增加额 | 72,203,173.29 | -16,327,085.62 | 24,789,126.81 | 142,595,393.86 |
| 期末现金及现金等价物余额 | 404,776,268.99 | 316,246,010.08 | 357,362,222.51 | 332,573,095.7 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -16,327,085.62 | - | 142,595,393.86 |
最新报告期：2026-11-03| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 西南证券 | 杜向阳,汤泰萌 | 1.08 | 1.38 | 1.58 | 2026-11-03 |
| 首创证券 | 王斌 | 1.16 | 1.39 | 1.68 | 2026-09-08 |
| 太平洋 | 张懿,谭紫媚 | 1.08 | 1.22 | 1.58 | 2026-09-02 |